{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:46:59Z","timestamp":1790470019720,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jcv.2020.104690","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T12:48:38Z","timestamp":1605617318000},"page":"104690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Comparison of SARS-CoV-2 serological tests with different antigen targets"],"prefix":"10.1016","volume":"134","author":[{"given":"Alix T.","family":"Coste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Jaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthaios","family":"Papadimitriou-Olivgeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Greub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Croxatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcv.2020.104690_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.micinf.2020.01.004","article-title":"Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses","volume":"22","author":"Chen","year":"2020","journal-title":"Microbes Infect."},{"issue":"5","key":"10.1016\/j.jcv.2020.104690_bib0010","doi-asserted-by":"crossref","first-page":"e1008536","DOI":"10.1371\/journal.ppat.1008536","article-title":"The hallmarks of COVID-19 disease","volume":"16","author":"Tang","year":"2020","journal-title":"PLoS Pathog."},{"issue":"10225","key":"10.1016\/j.jcv.2020.104690_bib0015","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","article-title":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2020.104690_bib0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virusres.2014.03.018","article-title":"Serological assays for emerging coronaviruses: challenges and pitfalls","volume":"194","author":"Meyer","year":"2014","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.jcv.2020.104690_bib0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/22221751.2020.1729071","article-title":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes","volume":"9","author":"Zhang","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"5-6","key":"10.1016\/j.jcv.2020.104690_bib0030","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.micinf.2005.02.006","article-title":"Antibody responses to individual proteins of SARS coronavirus and their neutralization activities","volume":"7","author":"Qiu","year":"2005","journal-title":"Microbes Infect."},{"issue":"48","key":"10.1016\/j.jcv.2020.104690_bib0035","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jcv.2020.104690_bib0040","doi-asserted-by":"crossref","first-page":"104820","DOI":"10.1016\/j.antiviral.2020.104820","article-title":"Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2","volume":"179","author":"Tai","year":"2020","journal-title":"Antiviral Res."},{"issue":"4","key":"10.1016\/j.jcv.2020.104690_bib0045","first-page":"203","article-title":"Serological assays for SARS-CoV-2 infectious disease: benefits, limitations and perspectives","volume":"22","author":"Infantino","year":"2020","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.jcv.2020.104690_bib0050","unstructured":"Okba, N.M.A., et al., 2020."},{"issue":"2","key":"10.1016\/j.jcv.2020.104690_bib0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and Antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jcv.2020.104690_bib0060","first-page":"665","article-title":"Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus","volume":"11","author":"Woo","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"5","key":"10.1016\/j.jcv.2020.104690_bib0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","volume":"20","author":"To","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2020.104690_bib0070","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2020.104690_bib0075","article-title":"Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results","author":"Caruana","year":"2020","journal-title":"CMI"},{"issue":"1","key":"10.1016\/j.jcv.2020.104690_bib0080","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1080\/22221751.2020.1762515","article-title":"Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients","volume":"9","author":"Sun","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jcv.2020.104690_bib0085","first-page":"1","article-title":"Serological differentiation between COVID-19 and SARS infections","author":"Chia","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"7","key":"10.1016\/j.jcv.2020.104690_bib0090","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.jcv.2020.104690_bib0095","article-title":"Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies","author":"Fenwick","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2020.104690_bib0100","article-title":"Indication for SARS-CoV-2 serology: first month follow-up","author":"Coste","year":"2020","journal-title":"Clin. Microbiol. Infect. Dis."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653220304327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653220304327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:13:30Z","timestamp":1761362010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653220304327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":20,"alternative-id":["S1386653220304327"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104690","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.09.20149864","asserted-by":"object"}]},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of SARS-CoV-2 serological tests with different antigen targets","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104690"}}